NASDAQ:NUTX

Nutex Health (NUTX) Stock Price, News & Analysis

$0.67
+0.00 (+0.48%)
(As of 04:00 PM ET)
Today's Range
$0.65
$0.70
50-Day Range
$0.53
$1.83
52-Week Range
$0.50
$9.45
Volume
289,229 shs
Average Volume
241,410 shs
Market Capitalization
$33.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00

Nutex Health MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
2,139.1% Upside
$15.00 Price Target
Short Interest
Healthy
0.24% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.40 out of 5 stars

Medical Sector

479th out of 909 stocks

Business Services, Not Elsewhere Classified Industry

63rd out of 87 stocks

NUTX stock logo

About Nutex Health Stock (NASDAQ:NUTX)

Nutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. The Population Health Management segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment leases land and hospital building. It also provides healthcare and facility management services; and healthcare billing, coding, and collection services. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

NUTX Stock Price History

NUTX Stock News Headlines

Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Nutex Health, Inc.: Nutex Health Provides Corporate Update
NUTEX HEALTH PROVIDES CORPORATE UPDATE
Why Is Nutex Health (NUTX) Stock Down 13% Today?
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Nutex Prices Direct Offering, Stock Plummets In Pre-market
See More Headlines
Receive NUTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/28/2024
Today
4/24/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:NUTX
Employees
1,150
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.00
High Stock Price Target
$15.00
Low Stock Price Target
$15.00
Potential Upside/Downside
+2,149.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-45,790,000.00
Pretax Margin
-19.58%

Debt

Sales & Book Value

Annual Sales
$247.65 million
Book Value
$1.77 per share

Miscellaneous

Free Float
25,616,000
Market Cap
$33.15 million
Optionable
Not Optionable
Beta
0.44
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Dr. Thomas T. Vo M.B.A. (Age 51)
    M.D., Chairman of the Board & CEO
    Comp: $938.23k
  • Dr. Warren Hosseinion M.D. (Age 52)
    President & Director
    Comp: $937.66k
  • Mr. Jon C. Bates CPA (Age 53)
    M.B.A., Chief Financial Officer
    Comp: $299.46k
  • Ms. Pamela W. Montgomery B.S.N. (Age 58)
    J.D., L.L.M., M.S.N., R.N., Chief Legal Officer of Healthcare & Board Secretary
    Comp: $275.36k
  • Ms. Elisa Michael Luqman Esq. (Age 60)
    J.D., M.B.A., Chief Legal Officer (SEC) & Board Secretary
    Comp: $251.33k
  • Mr. Joshua DeTillio FACHE
    M.B.A., Chief Operating Officer
  • Ms. LaChoenda Rosales
    Director of Accounting
  • LaTanya Brackens
    Director of Compliance
  • Ms. Vivian Sanders M.B.A.
    Director of Marketing
  • Sarah Wallace
    Director of Human Resources

NUTX Stock Analysis - Frequently Asked Questions

Should I buy or sell Nutex Health stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutex Health in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NUTX shares.
View NUTX analyst ratings
or view top-rated stocks.

What is Nutex Health's stock price target for 2024?

1 Wall Street research analysts have issued 1 year target prices for Nutex Health's stock. Their NUTX share price targets range from $15.00 to $15.00. On average, they expect the company's share price to reach $15.00 in the next year. This suggests a possible upside of 2,139.1% from the stock's current price.
View analysts price targets for NUTX
or view top-rated stocks among Wall Street analysts.

How have NUTX shares performed in 2024?

Nutex Health's stock was trading at $2.70 at the beginning of the year. Since then, NUTX stock has decreased by 75.2% and is now trading at $0.6699.
View the best growth stocks for 2024 here
.

Are investors shorting Nutex Health?

Nutex Health saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 1,030,000 shares, a drop of 29.9% from the March 15th total of 1,470,000 shares. Based on an average daily trading volume, of 2,000,000 shares, the short-interest ratio is currently 0.5 days. Approximately 0.2% of the company's stock are short sold.
View Nutex Health's Short Interest
.

When is Nutex Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our NUTX earnings forecast
.

How were Nutex Health's earnings last quarter?

Nutex Health Inc. (NASDAQ:NUTX) posted its quarterly earnings results on Thursday, March, 28th. The company reported ($0.75) earnings per share for the quarter. The business had revenue of $69.67 million for the quarter. Nutex Health had a negative trailing twelve-month return on equity of 45.58% and a negative net margin of 18.49%.

When did Nutex Health's stock split?

Nutex Health's stock reverse split on the morning of Wednesday, April 10th 2024. The 1-15 reverse split was announced on Wednesday, April 10th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, April 10th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Who are Nutex Health's major shareholders?

Nutex Health's stock is owned by many different retail and institutional investors. Top institutional investors include One Plus One Wealth Management LLC (0.71%). Insiders that own company stock include John J Waters, Joshua Detillio, Michael Lee Reed, Pamela W Montgomery and Thomas T Vo.
View institutional ownership trends
.

How do I buy shares of Nutex Health?

Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NUTX) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners